Cargando…

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes

Initiating insulin therapy with a basal insulin analogue has become a standard of care in the treatment of type 2 diabetes mellitus (T2DM). Despite increasing choices in pharmacological approaches, intensified glucose monitoring and improvements in quality of care, many patients do not achieve the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forst, Thomas, Choudhary, Pratik, Schneider, Doron, Linetzky, Bruno, Pozzilli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519070/ https://www.ncbi.nlm.nih.gov/pubmed/33098260 http://dx.doi.org/10.1002/dmrr.3418

Ejemplares similares

The importance of the initial period of basal insulin titration in people with diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
por: Berard, Lori, et al.
Publicado: (2018)

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
por: Barbieri, Douglas Eugenio, et al.
Publicado: (2015)

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
por: Rojas, Arturo, et al.
Publicado: (2016)

Call for Submissions: New Clinical Diabetes Department Focuses on Quality Improvement and Practice Transformation Initiatives
por: Schneider, Doron
Publicado: (2017)

Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes
por: Zhang, Puhong, et al.
Publicado: (2023)

Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data
por: Linetzky, Bruno, et al.
Publicado: (2016)

Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus
por: Chan, Siew Pheng, et al.
Publicado: (2022)

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US
por: Hoog, Meredith, et al.
Publicado: (2023)

Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
por: Attri, Bhawna, et al.
Publicado: (2020)

Comparing Glucose Outcomes Following Face-to-Face and Remote Initiation of Flash Glucose Monitoring in People Living With Diabetes
por: Kingsnorth, Andrew P., et al.
Publicado: (2023)

Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes
por: Swinnen, S. G. H. A., et al.
Publicado: (2009)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai, Samaneh, et al.
Publicado: (2020)

Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary
por: Anderson, John, et al.
Publicado: (2020)

A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
por: Miyoshi, Hideaki, et al.
Publicado: (2021)

Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
por: Mehta, Roopa, et al.
Publicado: (2021)

A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes
por: Edelman, Steven, et al.
Publicado: (2007)

Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
por: Raccah, D., et al.
Publicado: (2017)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)
por: Riddle, Matthew C., et al.
Publicado: (2013)

A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
por: Bonafede, Machaon MK, et al.
Publicado: (2010)

Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short‐acting and other glucagon‐like peptide‐1 receptor agonists
por: Giorgino, Francesco, et al.
Publicado: (2016)

The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8
por: Harris, Cynthia, et al.
Publicado: (2017)

Stepwise intensification of insulin therapy in Type 2 diabetes management—exploring the concept of the basal-plus approach in clinical practice
por: Owens, D R
Publicado: (2013)

Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
por: Tobin, G S, et al.
Publicado: (2012)

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
por: Khunti, K., et al.
Publicado: (2016)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
por: Mehta, Roopa, et al.
Publicado: (2022)

Expert Opinion on Diabetes Management Challenges and Role of Basal Insulin/GLP-1 RA Fixed-Ratio Combination in People with Type 2 Diabetes from Indonesia
por: Suastika, Ketut, et al.
Publicado: (2022)

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study
por: Pantalone, Kevin M., et al.
Publicado: (2023)

The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond
por: Choudhary, Pratik, et al.
Publicado: (2021)

Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Basal-bolus insulin therapy in postoperative inpatients with diabetes mellitus: directions for future quality-improvement initiatives
por: Cook, Curtiss B, et al.
Publicado: (2017)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes
por: Forst, Thomas, et al.
Publicado: (2010)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
por: Nasrallah, Sami N., et al.
Publicado: (2012)

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
por: Home, Philip, et al.
Publicado: (2014)

Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetes
por: Forst, T, et al.
Publicado: (2010)

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study
por: Hanefeld, Markolf, et al.
Publicado: (2011)

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis
por: Raccah, Denis, et al.
Publicado: (2019)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r0hmar9pm71mo4hebrmtsks59s